Loading stock…

Vericel Corporation (VCEL) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Vericel Corporation

VCELMarket cap $2.05BPrice $40.0

Country🇺🇸United States

SectorHealthcare

IndustryBiotechnology

Develops and sells cell therapies that regrow cartilage and repair severe burns using a patient's own cells. Its skin substitute is the only FDA-approved product of its kind for treating life-threatening burns in both adults and kids.

In Bastion Portfolios?

52W Return+13%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+19%9

Revenue Forecast

Rev CAGR (1y)+22%8

Rev CAGR (3y)+18%9

Rev CAGR (5y)+19%9

Earnings Forecast

EPS Growth Y+1+59%9

EPS Growth Y+2+59%9

EPS Growth Y+3+59%9

Quality

Margins

EBIT Margin6%3

Net Income Margin8%5

Free Cash Flow Margin20%8

Debt

Net Debt/EBITDA-1.610

Efficiency

ROE7%3

ROA5%6

Earnings Stability66

GEAR+AVERAGE66

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)571

P/E Ratio (Forward 3y)301

P/BV5.53

EV Multiples

EV/EBITDA Fwd222

EV/EBIT Fwd701

Yield

Free Cash Flow Yield3.0%5

Dividend Yieldna–

Momentum

Short term

1 month return+3%9

3 month return-17%2

YTD return+11%7

Mid term

Price vs 52wHigh81%6

1 year return+22%7

Long term

3 year return+17%4

5 year return-22%2

Risk Shield

Price Risk

Beta0.86

Volatility41%4

Free Cash Flow

Free Cash Flow Margin20%8

Free Cash Flow Yield3.0%5

Quality

ROCE4%3

Earnings Stability66

Net Debt/EBITDA-1.610

02Growth

Is it actually growing, and how fast?

VCELVericel

Revenue FY25$276M

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+19%9

Revenue, next 1Y+22%8

Revenue, next 3Y, CAGR+18%9

Revenue, next 5Y, CAGR+19%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+59%9

EPS growth, FY27E+59%9

EPS growth, FY28E+59%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 19%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 18%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 19%/yr over the last 3 years and is set to keep growing around 18%/yr.

The runway holds up: revenue is set to grow 19%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 59%/yr vs revenue 18%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE36 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+3%9

3-month return-17%2

YTD return+11%7

MID & LONG-TERM▾SCORE

% of 52-week high81%6

1-year return+22%7

3-year return+17%4

5-year return-22%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 22% over the past year, but 19% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+3%) and so far this year (+11%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+17% over three years and -22% over five), behind 70% of the market.

The stock is underperforming over three months (-17%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Vericel Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

VCELVericel

Revenue FY25$276M

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+19%9

Revenue, next 1Y+22%8

Revenue, next 3Y, CAGR+18%9

Revenue, next 5Y, CAGR+19%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+59%9

EPS growth, FY27E+59%9

EPS growth, FY28E+59%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 19%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 18%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 19%/yr over the last 3 years and is set to keep growing around 18%/yr.

The runway holds up: revenue is set to grow 19%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 59%/yr vs revenue 18%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE36 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+3%9

3-month return-17%2

YTD return+11%7

MID & LONG-TERM▾SCORE

% of 52-week high81%6

1-year return+22%7

3-year return+17%4

5-year return-22%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 22% over the past year, but 19% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+3%) and so far this year (+11%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+17% over three years and -22% over five), behind 70% of the market.

The stock is underperforming over three months (-17%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Vericel Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community